Commercial due diligence on healthcare businesses

For investors in hospitals, clinic groups, pharmacies, laboratories and the companies that supply them.

Healthcare in the capital markets

Healthcare listings raised $508 million across the Gulf in 2025, including SMC Hospitals on the Saudi Main Market and Basma Adeem and Wajd Life on Nomu [1]. Listed valuations give private buyers a reference point, and sellers know it.

That makes it more important to know whether a target's growth comes from the market or from a few doctors, a few contracts or a single location.

What we test

Typical questions on a healthcare target

Who pays, and on what terms?Payer mix across government, insurers and self-pay; claims rejection
Is there demand in the catchment?Population, competing facilities, patient travel patterns
Where do patients come from?Referral sources, corporate contracts, physician loyalty
Can it recruit and keep clinicians?Interviews with staff and recruiters, pay benchmarks
How exposed is it to licensing and pricing?Regulatory steps for new sites, tariff changes

Doctors, not just beds

In many clinic groups a small number of consultants drive a large share of revenue. If they leave, patients often follow. We look at how revenue splits by clinician, how long key people have been there, and what keeps them.

For expansion plans, we test whether the new locations have the patient demand, the payer contracts and the staff to open on time.

Questions

Do you speak to patients?

Rarely, and only with care. We usually learn more from referrers, insurers, corporate clients and staff.

Do you cover medical devices and pharmaceuticals?

Yes, including distributors, where agency agreements and tender wins drive the plan.

Tell us about the deal

Send a few lines on the target and your timing, and we'll arrange a scoping call.